Orexo AB: Interim Report, January-March 2013
4/26/2013 6:33:24 AM
More...
|
Number of Shares and Votes in Orexo AB
3/28/2013 10:01:02 AM
More...
|
Orexo AB Announces Divestiture of Abstral in the U.S. for $10 Million Upfront
3/18/2013 7:01:45 AM
More...
|
Notice of Annual General Meeting of Orexo AB
3/12/2013 9:43:12 AM
More...
|
Nikolaj Sorensen Appointed as New CEO at Orexo AB
2/5/2013 7:26:25 AM
More...
|
Number of Shares and Votes in Orexo AB
1/31/2013 10:22:57 AM
More...
|
Number of Shares and Votes in Orexo AB
12/28/2012 9:00:02 AM
More...
|
Orexo AB Provides US Commercialization Progress Update and Direction for 2013 Financial Outlook
12/19/2012 9:20:20 AM
More...
|
FDA Accepts Orexo AB Zubsolv New Drug Application
11/19/2012 6:49:31 AM
More...
|
Orexo AB Announces Submission of a New Drug Application for KW-2246 (Abstral®) in Japan
11/13/2012 10:25:44 AM
More...
|
|